Insider · CIK 0001579829

Ignelzi Troy A.

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001579829

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2026-04-02	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+17.7K sh	—	—	17,710
2026-02-02	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+148K sh	—	—	148,000
2025-06-26	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.8K sh	—	—	14,750
2025-03-13	RAPPRapport Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+100 sh	$9.98	+$998	10,000
2025-03-12	RAPPRapport Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+9,900 sh	$10.10	+$100K	9,900
2025-02-03	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+142K sh	—	—	142,000
2024-06-06	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+81.4K sh	—	—	81,366
2024-05-24	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,350 sh	—	—	6,350
2024-05-20	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.2K sh	—	—	23,150
2023-08-22	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,500 sh	—	—	93,226
2023-08-22	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,500 sh	$9.20	+$13.8K	31,987
2023-08-22	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−855 sh	$174.88	−$150K	31,052
2023-08-22	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−505 sh	$175.59	−$88.7K	30,547
2023-08-22	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−80 sh	$173.64	−$13.9K	31,907
2023-08-22	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−60 sh	$176.60	−$10.6K	30,487
2023-05-23	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−782 sh	$225.93	−$177K	30,487
2023-05-23	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,070 sh	$224.19	−$240K	32,291
2023-05-23	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−9,000 sh	—	—	94,726
2023-05-23	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,022 sh	$225.19	−$230K	31,269
2023-05-23	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,093 sh	$222.24	−$465K	36,670
2023-05-23	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,309 sh	$223.21	−$739K	33,361
2023-05-23	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−724 sh	$221.28	−$160K	38,763
2023-05-23	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+9,000 sh	$9.20	+$82.8K	39,487
2023-02-24	CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.3K sh	—	—	0
2023-02-24	CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−58.8K sh	—	—	0
2023-02-21	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,000 sh	$9.20	+$55.2K	36,487
2023-02-21	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,000 sh	—	—	103,726
2023-02-21	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−6,000 sh	$190.01	−$1.14M	30,487
2023-02-09	Karuna Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+8,650 sh	—	—	30,487
2023-02-09	Karuna Therapeutics, Inc.Option (right to buy)A Award	Chief Financial Officer	AAward	+17.4K sh	—	—	17,350
2023-01-18	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−200 sh	—	—	109,726
2023-01-18	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+200 sh	$9.20	+$1,840	22,037
2023-01-18	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−200 sh	$200.14	−$40K	21,837
2023-01-17	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−817 sh	$201.41	−$165K	21,837
2023-01-17	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−817 sh	—	—	109,926
2023-01-17	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+817 sh	$9.20	+$7,516.4	22,654
2022-12-16	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−627 sh	—	—	626
2022-12-16	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−371 sh	—	—	8,559
2022-12-16	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10.9K sh	—	—	110,743
2022-12-16	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+627 sh	$9.20	+$5,768.4	21,837
2022-12-16	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+371 sh	$9.20	+$3,413.2	21,210
2022-12-16	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10.9K sh	$9.20	+$100K	20,839
2022-11-15	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−16.5K sh	—	—	121,612
2022-11-15	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−16.5K sh	$225.85	−$3.73M	9,970
2022-11-15	Karuna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+16.5K sh	$9.20	+$152K	26,470
2022-10-04	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−400 sh	$233.20	−$93.3K	9,970
2022-10-03	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,100 sh	$232.00	−$255K	10,370
2022-10-03	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$231.30	−$463K	11,470
2022-10-03	Karuna Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,000 sh	$230.02	−$230K	13,470

Recent filings

Accepted (ET)
Jun 264
Ignelzi Troy A.0001628280-26-045837
SEC(opens sec.gov)
Apr 64
Ignelzi Troy A.0001579829-26-000003
SEC(opens sec.gov)
Feb 44
Ignelzi Troy A.0001193125-26-037587
SEC(opens sec.gov)
Jun 264
Ignelzi Troy A.0001437749-25-021369
SEC(opens sec.gov)
Mar 134
Ignelzi Troy A.0000950170-25-038878
SEC(opens sec.gov)
Feb 44
Ignelzi Troy A.0000950170-25-013754
SEC(opens sec.gov)
Jun 104
Ignelzi Troy A.0000950170-24-071527
SEC(opens sec.gov)
May 294
Ignelzi Troy A.0001437749-24-018622
SEC(opens sec.gov)
May 204
Ignelzi Troy A.0001437749-24-017719
SEC(opens sec.gov)
Aug 244
Ignelzi Troy A.0000950170-23-044413
SEC(opens sec.gov)
May 254
Ignelzi Troy A.0000950170-23-024286
SEC(opens sec.gov)

Companies

Address

3565 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121